日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A vitamin D-based strategy overcomes chemoresistance in prostate cancer

基于维生素 D 的策略可克服前列腺癌的化学耐药性

Kateryna Len-Tayon, Claire Beraud, Clara Fauveau, Anna Y Belorusova, Yassmine Chebaro, Antonio Mouriño, Thierry Massfelder, Anne Chauchereau, Daniel Metzger, Natacha Rochel, Gilles Laverny

Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome

在治疗性疫苗接种之前或同时抑制半乳糖凝集素-3对于实现前列腺肿瘤完全消退至关重要。

Tiraboschi, Carolina; Gentilini, Lucas; Velazquez, Carla; Corapi, Enrique; Jaworski, Felipe Martín; Garcia Garcia, José Daniel; Rondón, Yorfer; Chauchereau, Anne; Laderach, Diego José; Compagno, Daniel

Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing

利用鸡胚绒毛尿囊膜 (CAM) 作为抗转移药物测试的平台

P Pawlikowska, T Tayoun, M Oulhen, V Faugeroux, V Rouffiac, A Aberlenc, A L Pommier, A Honore, V Marty, O Bawa, L Lacroix, J Y Scoazec, A Chauchereau, C Laplace-Builhe, F Farace

Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease

一组前列腺癌细胞系对恩杂鲁胺的反应揭示了糖皮质激素受体在恩杂鲁胺耐药性疾病中的作用

Rebecca Smith, Moqing Liu, Tiera Liby, Nora Bayani, Elmar Bucher, Kami Chiotti, Daniel Derrick, Anne Chauchereau, Laura Heiser, Joshi Alumkal, Heidi Feiler, Peter Carroll, James E Korkola

Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer

半乳糖凝集素-8的稳定高表达严格控制着前列腺癌的转移进展。

Gentilini, Lucas Daniel; Jaworski, Felipe Martín; Tiraboschi, Carolina; Pérez, Ignacio González; Kotler, Monica Lidia; Chauchereau, Anne; Laderach, Diego Jose; Compagno, Daniel

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis

敲低 Clusterin 可通过调节有丝分裂使前列腺癌细胞对紫杉烷敏感

Nader Al Nakouzi, Chris Kedong Wang, Eliana Beraldi, Wolfgang Jager, Susan Ettinger, Ladan Fazli, Lucia Nappi, Jennifer Bishop, Fan Zhang, Anne Chauchereau, Yohann Loriot, Martin Gleave

Functional Assessment of Genetic Variants with Outcomes Adapted to Clinical Decision-Making

基因变异的功能评估及其结果适应临床决策

Thouvenot, Pierre; Ben Yamin, Barbara; Fourrière, Lou; Lescure, Aurianne; Boudier, Thomas; Del Nery, Elaine; Chauchereau, Anne; Goldgar, David E; Houdayer, Claude; Stoppa-Lyonnet, Dominique; Nicolas, Alain; Millot, Gaël A

Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer.

靶向 CDC25C、PLK1 和 CHEK1 以克服前列腺癌中 LZTS1 缺失引起的多西他赛耐药性。

Al Nakouzi Nader, Cotteret Sophie, Commo Frédéric, Gaudin Catherine, Rajpar Shanna, Dessen Philippe, Vielh Philippe, Fizazi Karim, Chauchereau Anne

The IGR-CaP1 xenograft model recapitulates mixed osteolytic/blastic bone lesions observed in metastatic prostate cancer

IGR-CaP1异种移植模型重现了转移性前列腺癌中观察到的混合性溶骨/成骨性骨病变。

Al Nakouzi, Nader; Bawa, Olivia; Le Pape, Alain; Lerondel, Stéphanie; Gaudin, Catherine; Opolon, Paule; Gonin, Patrick; Fizazi, Karim; Chauchereau, Anne

Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer

干细胞标志物表征了 IGR-CaP1,这是一种源自原发性上皮性前列腺癌的新细胞系

Anne Chauchereau, Nader Al Nakouzi, Catherine Gaudin, Sylvestre Le Moulec, Daniel Compagno, Nathalie Auger, Jean Bénard, Paule Opolon, François Rozet, Pierre Validire, Gaëlle Fromont, Karim Fizazi